1. A Breathprint for Malaria: New Opportunities for Noninterventional Diagnostics and Mosquito Traps?. (3rd February 2018) Authors: Fidock, David A Journal: Journal of infectious diseases Issue: Volume 217:Number 10(2018) Page Start: 1512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the Plasmodium Phosphatidylinositol 4-Kinase Inhibitor MMV390048. (2nd April 2020) Authors: McCarthy, James S; Donini, Cristina; Chalon, Stephan; Woodford, John; Marquart, Louise; Collins, Katharine A; Rozenberg, Felix D; Fidock, David A; Cherkaoui-Rbati, Mohammed H; Gobeau, Nathalie; Möhrle, Jörg J Journal: Clinical infectious diseases Issue: Volume 71:Number 10(2020) Page Start: e657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study. Issue 2 (February 2017) Authors: Witkowski, Benoit; Duru, Valentine; Khim, Nimol; Ross, Leila S; Saintpierre, Benjamin; Beghain, Johann; Chy, Sophy; Kim, Saorin; Ke, Sopheakvatey; Kloeung, Nimol; Eam, Rotha; Khean, Chanra; Ken, Malen; Loch, Kaknika; Bouillon, Anthony; Domergue, Anais; Ma, Laurence; Bouchier, Christiane; Leang, R... Journal: Lancet infectious diseases Issue: Volume 17:Issue 2(2017:Feb.) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Accelerated evolution and spread of multidrug-resistant Plasmodium falciparum takes down the latest first-line antimalarial drug in southeast Asia. Issue 9 (September 2019) Authors: Ménard, Didier; Fidock, David A Journal: Lancet infectious diseases Issue: Volume 19:Issue 9(2019) Page Start: 916 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. Issue 8 (August 2018) Authors: Llanos-Cuentas, Alejandro; Casapia, Martin; Chuquiyauri, Raúl; Hinojosa, Juan-Carlos; Kerr, Nicola; Rosario, Maria; Toovey, Stephen; Arch, Robert H; Phillips, Margaret A; Rozenberg, Felix D; Bath, Jade; Ng, Caroline L; Cowell, Annie N; Winzeler, Elizabeth A; Fidock, David A; Baker, Mark; Möhrle, ... Journal: Lancet infectious diseases Issue: Volume 18:Issue 8(2018) Page Start: 874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity. (17th July 2017) Authors: Agrawal, Sonia; Moser, Kara A; Morton, Lindsay; Cummings, Michael P; Parihar, Ankita; Dwivedi, Ankit; Shetty, Amol C; Drabek, Elliott F; Jacob, Christopher G; Henrich, Philipp P; Parobek, Christian M; Jongsakul, Krisada; Huy, Rekol; Spring, Michele D; Lanteri, Charlotte A; Chaorattanakawee, Suwan... Journal: Journal of infectious diseases Issue: Volume 216:Number 4(2017:Aug. 15) Page Start: 468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials. (9th September 2022) Authors: Wicht, Kathryn J; Small-Saunders, Jennifer L; Hagenah, Laura M; Mok, Sachel; Fidock, David A Journal: Journal of infectious diseases Issue: Volume 226:Number 11(2022) Page Start: 2021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Parasite‐induced ER stress response in hepatocytes facilitates Plasmodium liver stage infection. (25th June 2015) Authors: Inácio, Patricia; Zuzarte‐Luís, Vanessa; Ruivo, Margarida TG; Falkard, Brie; Nagaraj, Nagarjuna; Rooijers, Koos; Mann, Matthias; Mair, Gunnar; Fidock, David A; Mota, Maria M Journal: EMBO reports Issue: Volume 16:Number 8(2015:Aug.) Page Start: 955 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Plasmodium falciparum resistance to artemisinin-based combination therapies. (October 2022) Authors: Ward, Kurt E; Fidock, David A; Bridgford, Jessica L Journal: Current opinion in microbiology Issue: Volume 69(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Plasmodium falciparum resistance to piperaquine driven by PfCRT. Issue 11 (November 2019) Authors: Dhingra, Satish K; Small-Saunders, Jennifer L; Ménard, Didier; Fidock, David A Journal: Lancet infectious diseases Issue: Volume 19:Issue 11(2019) Page Start: 1168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗